Collaborative Studies on Lung Stem Cell Biology and Cell Based Therapy (R01)
The summary for the Collaborative Studies on Lung Stem Cell Biology and Cell Based Therapy (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Studies on Lung Stem Cell Biology and Cell Based Therapy (R01): -The purpose of this RFA is to foster research on lung stem cell biology and cell based therapy for lung diseases. This program will support regular research grants (R01s), which include collaborations between basic scientists and clinical investigators who will explore together clinically relevant questions, thereby enabling basic science findings to be more readily translated into studies that investigate the potential of cell based therapy for preventing and treating lung disease. An important goal of this program is to provide the basic knowledge necessary to eventually develop safe and efficacious clinical protocols on lung cell based therapy. -This funding opportunity will use the NIH R01 research grant award mechanism. The total amount to be awarded is $20 million over 4 years. A single application for a research grant application should not request more than $500,000 direct cost in any single year. The anticipated number of awards is 6-7. -Eligible organizations include: For-profit organizations; non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; foreign institutions and organizations are not eligible to apply. However, collaborations with foreign institutions may be allowable with proper justification(s); units of state government; units of local government; and eligible agencies of the federal government. -Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Each applicant may submit only one application. -See Section IV.1 for application materials. -Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Federal Grant Title: | Collaborative Studies on Lung Stem Cell Biology and Cell Based Therapy (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HL-07-003 |
Type of Funding: | Grant |
CFDA Numbers: | 93.838 |
CFDA Descriptions: | Lung Diseases Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Apr 26, 2006 |
Creation Date: | Apr 27, 2006 |
Archive Date: | Jan 12, 2007 |
Total Program Funding: | $20,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Special district governments County governments State governments
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
- • Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
- • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...